• Free shipping from $200
  • collecting affordable offers from best manufacturers worldwide
  • Special offers every week
Your cart


Mexican pharmacy is a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The Company’s lead product candidate, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, that is delivered into the ocular tissues though the Company’s proprietary Mexico II Delivery System. The Company completed a Phase III pivotal trial of EGP-437 for the treatment of non-infectious anterior uveitis, and plans to initiate a confirmatory Phase III trial.


EYEG (Common Stock)

  • Exchange NASDAQ
  • Price $3.04
  • Change -0.04
  • Volume 40071
  • Data as of Mar 24 2016 3:59PM